Find the latest pharmaceutical market place for formulations enquiry about Azacitidine on PharmaCompass.com.

Market Place

Tender// Azacitidine (100 mg) Injections needed in Poland [ENA17840]

Independent Public Health Care Center of the Ministry of Internal Affairs and Administration in Pozna, named after prof. Ludwika Bierkowskiego is looking for supplies of Azacitidine (100 mg) Injections for commercial purposes. The required quantity is 3,400 units. The deadline is 28-August-2023.

Reply

18 Aug 2023

Tender// Various Finished Dosage Formulations needed in Poland [ENA17447]

Szpital Uniwersytecki W Krakowie is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 27-July-2023.
1. Cyclophosphamide (1000 mg) Injections. The required quantity is 3,060 units.
2. Azacitidine (100 mg) Injections. The required quantity is 4,500 units.

Reply

03 Jul 2023

CzechRepublic Flag

Tender// Azacitidine (25 mg/ ml) Injections needed in Czech Republic [ENA17445]

Fakultni nemocnice Hradec Kralove is looking for supplies of Azacitidine (25 mg/ ml) Injections for commercial purposes. The required quantity is 37,440 units. The deadline is 28-July-2023.

Reply

01 Jul 2023

CzechRepublic Flag

Tender// Azacitidine (25 mg/ ml) Injections needed in Czech Republic [ENA17406]

Faculty Hospital Hradec Kralove is looking for supplies of Azacitidine (25 mg/ ml) Injections for commercial purposes. The required quantity is 37,440 units. The deadline is 24-July-2023.

Reply

27 Jun 2023

Tender// Azacitidine (100 mg) Injections needed in Poland [ENA16822]

Szpitale Pomorskie Sp. z o.o. is looking for supplies of Azacitidine (100 mg) Injections for commercial purposes. The required quantity is 1,600 units. The deadline is 8-May-2023.

Reply

06 Apr 2023

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA11836]

University Multiprofile Hospital For Active Treatment - Dr. Georgi Stranski EAD is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 14-Dec-2021.
1. Ondansetron (8 mg) Ampoules. The required quantity is 88,000 units.
2. Eltrombopag (25 mg) Tablets. The required quantity is 147,000 units.
3. Dexamethasone (4 mg) Ampoules. The required quantity is 100,000 units.
4. Cyclophosphamide (500 mg) Ampoules. The required quantity is 600,000 units.
5. Chlorambucil (2 mg) Tablets. The required quantity is 10,000 units.
6. Ifosfamide (2000 mg) Ampoules. The required quantity is 480,000 units.
7. Temozolomide (100 mg) Hard Capsules. The required quantity is 200,000 units.
8. Mercaptopurine (50 mg) Tablets. The required quantity is 375,000 units.
9. Capecitabine (500 mg) Tablets. The required quantity is 25,200,000 units.
10. Azacitidine (100 mg) Ampoules. The required quantity is 120,000 units.

Reply

10 Nov 2021

Tender// Various Finished Dosage Formulations needed in Poland [ENA11059]

Independent Public Clinical Hospital No. 1 PUM is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 7-Sep-2021.
1. Azacitidine (0.1 g / 4 ml) Powder for Suspension for Injection. The required quantity is 2,800 units.
2. Ibrutinib (140 mg) Hard Capsules. The required quantity is 240 units.
3. Docetaxel (20 mg / 2 ml) Vials. The required quantity is 150 units.
4. Paclitaxel (300 mg / 50 ml) Vials. The required quantity is 350 units.
5. Gemcitabine (2000 mg / 50 ml) Vials. The required quantity is 450 units.
6. Fluorouracil (5000 mg / 100 ml) Vials. The required quantity is 950 units.
7. Oxaliplatin (100 mg / 20 ml) Vials. The required quantity is 1,400 units.
8. Irinotecan Hydrochloride Trihydrate (100 mg / 5 ml) Vials. The required quantity is 900 units.

Reply

07 Aug 2021

Russia-big Flag

Tender// Azacitidine (100 mg) Lyophilized Injections needed in Russia [ENA10258]

Omsk Region'S Regional Clinical Hospital is lookinf=g for supplies of Azacitidine (100 mg) Lyophilisate for the preparation of a Suspension for Subcutaneous Administration. The required quantity is 16,800 units. The deadline is 28-April-2021.

Reply

19 Apr 2021

Tender// Azacitidine (100 mg) Injections needed by AZ Delta vzw in Belgium [ENA09706]

AZ Delta vzw is looking for supplies of Azacitidine (100 mg) Injections. The required quantity is 6,384 units. The suppliers must support this tender with ESPD. The deadline is 9-March-2021.

Reply

10 Feb 2021

Tender// Various Finished Dosage Formulations needed by AZ Damiaan in Belgium [ENA09564]

AZ Damiaan is looking for suppliers of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 18-Feb-2021.
1. Bevacizumab (100 mg/ 4 ml and 400 mg/ 16 ml ) Injection. The required quantity is 3,600 units and 4,800 units respectively.
2. Fulvestrant (250 mg/ 5 ml) Injection. The required quantity is 3,600 units.
3. Azacitidine (100 mg) Injection. The required quantity is 2,250 units.

Reply

23 Jan 2021

United_States_of_America Flag

Azacitidine (100 mg) Vials needed in the United States [ENA09516]

An Independent Research Consultant is looking for suppliers of Azacitidine (100 mg) Vials for commercial purposes. The required quantity is 4,000 units. The suppliers must support this enquiry with USFDA.

Reply

18 Jan 2021

turkeypng-1602828403png-1622460951png-1622462103 Flag

Tender// Various Finished Dosage Formulations needed by Hastane Geneli Kemoterapi Ilaclari Alimi in Turkey [ENA09...

Hastane Geneli Kemoterapi Ilaclari Alimi is looking for supplies of medicinal products. The deadline is 10-Dec-2020.
1. Azacitidine (100 mg) Vials. The required quantity is 200 units.
2. Gemcitabine Hydrochloride (1000 mg). The required quantity is 500 units.
3. Methotrexate (50 mg) Ampoules. The required quantity is 100 units.
4. Mitomycin (20 mg) Vials. The required quantity is 20 units.
5. Paclitaxel (100 mg, 30 mg & 300 mg) Vials. The required quantity is 500 units, 500 units & 100 units respectively.
6. Rituximab (100 mg & 500 mg). The required quantity is 100 units for each.

Reply

30 Nov 2020

NewZealand Flag

Tender// Various Finished Formulations needed in New Zealand [ENA09072]

District Health Boards (DHBs) have a requirement for aseptically compounded pharmaceutical products and services (Aseptic Compounding) for a wide range of uses. The deadline is 30-Nov-2020.
1. Morphine (10mg/ml, 10 ml) Injections
2. Heparin (100 IU/ml, 2 ml) Injections
3. Vancomycin (1mg /0.1 ml) Intraocular Injections
4. Lidocaine (0.4% in 0.9% sodium chloride, 500 ml) Infusion Bag
5. Cytarabine (20 mg) Subcutaneous Injections
6. Methotrexate (12 mg) Intrathecal Injections
7. Azacitidine (75 mg in 3 ml) Subcutaneous Injections
8. Ganciclovir (500 mg in 0.9% sodium chloride, 100ml) Injections
9. Cyclophosphamide (800 mg/ 500 ml NS) Injections
10. Thiotepa (70 mg in 0.9% sodium chloride, 100ml) Injections
11. Trastuzumab (440 mg) Injections
12. Methotrexate (1 litre: 12.5 g in a litre of 0.9% sodium chloride) Infusion Bag
13. Rituximab (1g; 500 ml normal saline 0.9%) Injections
14. Mitomycin (0.04%; dilent normal saline 0.9%) Eye Drops

Reply

18 Nov 2020

Azacitidine (100 mg) Injections needed in France [ENA08809]

Enex Pharma, a company based in France that deals in the distribution of various pharmaceutical products is looking for suppliers of Azacitidine (100 mg) Injections. The required quantity is 11,000 units. The suppliers must support this enquiry with authorization in France. Interested suppliers can contact them via their email: sewa@enexpharma.com.

Reply

14 Oct 2020

Azacitidine 100 mg vials (8,000 - 9,000 units) needed in Italy [ENA03373]

One of the prominent learning and research institutes in Italy is looking for suppliers of Azacitidine 100 mg vials (8,000 - 9,000 units) for research purposes.

Reply

08 Feb 2019

Azacitidine 100 mg injections needed in Italy [ENA03323]

One of the prominent learning and research institutes in Italy is looking for suppliers of Azacitidine 100 mg injections for their research project.

Reply

02 Feb 2019

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.